The expression of vasoactive intestinal peptide receptor 1 is negatively modulated by microRNA 525-5p

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Cocco, Elisa ^a   Paladini, Fabiana ^a   Macino, Giuseppe ^b   Fulci, Valerio ^b   Fiorillo, Maria Teresa ^a   Sorrentino, Rosa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; LUCIFERASE; MICRORNA; MICRORNA 525 5P; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1;

3' UNTRANSLATED REGION; ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; MONOCYTE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; UPREGULATION; GENETICS; IMMUNOLOGY; METABOLISM;

BACTERIA (MICROORGANISMS);

3' UNTRANSLATED REGIONS; BASE SEQUENCE; DOWN-REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MICRORNAS; MONOCYTES; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; U937 CELLS; UP-REGULATION;

EID: 77957779189     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012067     Document Type: Article

References (42)

1. Barbezat GO, Grossman MI (1971) Intestinal secretion: stimulation by peptides. Science 174: 422-4.
2. Makhlouf GM, Murthy KS (1997) Signal transduction in gastrointestinal smooth muscle. Cell signal 9: 269-76.
3. Miampamba M, Germano PM, Arli S, Wong HH, Scott D, et al. (2002) Expression of pituitary adenylate cyclase-activating polipeptide and PACAP type I receptor in the rat gastric and colonic myenteric neurons. Regul Pept 105: 145-154.
4. Lelievre V, Favrais G, Abad C, Adle-Biassette H, Lu Y, et al. (2007) Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of Intestinal Ileus and Hirschsprung's disease. Peptides 28: 1688-1689.
5. Paladini F, Cocco E, Cascino I, Belfiore F, Badiali D, et al. (2009) Agedependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene. Neurogastroenterol Motil 21: 597-602.
6. Gomariz RP, Arranz A, Juarranz Y, Gutierrez-Cañas I, Garcia-Gomez M, et al. (2007) Regulation of TLR expression, a new perspective for the role of VIP in immunity. Peptides 28: 1825-1832.
7. Gonzales-Rey E, Chorny A, Delgado M (2007) Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 7: 52-63.
8. Leceta J, Gomariz RP, Martinez C, Carrión M, Arranz A (2007) Vasoactive Intestinal Peptide regulates Th17 function in autoimmune inflammation. Neuroimmunomodulation 14: 134-138.
9. Lodde BM, Mineshiba F, Wang J, Cotrim AP, Afione S, et al. (2006) Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome. Ann Rheum Dis 65: 195-200.
10. Gonzales-Rey E, Fernandez-Martin A, Chorny A, Delgado M (2006) Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. Arthritis and Rheum 54: 864-876.
11. Laburthe M, Couvineau A (2002) Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP. Regul Pept 108: 165-73.
12. Sreedharan SP, Huang JX, Cheung MC, Goetzl EJ (1995) Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc Natl Acad Sci 92: 2939-43.
13. Lara-Marquez M, O'Dorisio M, O'Dorisio T, Shah M, Karacay B (2001) Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. J Immunol 166: 2522-2530.
14. Toumi F, Neunlist M, Denis MG, Oreshkova T, Laboisse CL, et al. (2004) Vasoactive intestinal peptide induces IL-8 production in human colonic epithelial cells via MAP kinase-dependent and PKA-independent pathways. Biochem Biophys Res Commun 317: 187-91.
15. Kojima M, Ito T, Oono T, Hisano T, Igarashi H, et al. (2005) VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production. Pancreas 30: 62-70.
16. Gonzalez-Rey E, Chorny A, Fernandez-Martin A, Ganea D, Delgado M (2006) Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood 107: 3632-8.
17. Pozo D, Anderson P, Gonzalez-Rey E (2009) Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide. J Immunol 183: 4346-59.
18. Delgado M, Robledo G, Rueda B, Varela N, O'Valle F, et al. (2008) Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells. Arthritis Rheum 58: 1010-9.
19. Paladini F, Cocco E, Cauli A, Cascino I, Vacca A, et al. (2008) A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia. Genes Immun 9: 659-67.
20. Chu CY, Rana TM (2007) Small RNAs: regulators and guardians of the genome. J Cell Physiol 213: 412-9.
21. Hammonds SM (2005) Dicing and slicing: the core machinary of the RNA interference pathway. FEBS lett 579: 5822-9.
22. Doench JG, Sharp PA (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-11.
23. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flange by adenosines, indicates that thousand of human genes are micro RNA targets. Cell 120: 15-20.
24. Pauley KM, Cha S, Chan EK (2009) MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 32: 189-94.
25. Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY (2008) Dicerdependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205: 1993-2004.
26. Rigby RJ, Vinuesa CG (2008) SiLEncing SLE: the power and promise of small noncoding RNAs. Curr Opin Rheumatol 20: 526-31.
27. Tili E, Michaille JJ, Costinean S, Croce CM (2008) MicroRNAs, the immune system and rheumatic disease. Nat Clin Pract Rheumatol 4: 534-41.
28. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, et al. (2008) Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58: 1001-9.
29. Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, et al. (2010) An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115: 265-273.
30. Van der Bruggen T, Nijenhuis S, van Raaij E, Verhoef J, van Asbeck BS (1999) Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect Immun 67: 3824-3829.
31. Guha M, O'Connel MA, Pawlinski R, Hollis A, McGovern P, et al. (2001) Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98: 1429-1439.
32. Mackman N (1994) Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J Biol Chem 269: 26363-7.
33. Bennet BL, Sasaki DT, Murray BV, O'Leary EC, Sakata ST, et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci 98: 13681-13686.
34. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, et al. (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944-4951.
35. Martin AJ, Zhou L, Miller SD (2009) MicroRNA-managing the TH-17 inflammatory response. Nat Immunol 10: 1229-1231.
36. Nahid MA, Pauley KM, Satoh M, Chan EK (2009) miR-146a is critical for endotoxin-induced tolerance. Implication in Innate Immunity. J Biol Chem 284: 34590-99.
37. Stahl HF, Fauti T, Ullrich N, Bopp T, Kubach J, et al. (2009) miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression. PLoS One 4: e7158.
38. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
39. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, et al. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817-1821.
40. Saunders MA, Liang H, Li WH (2007) Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 104: 3300-3305.
41. Sethupathy P, Collins FS (2008) MicroRNA target site polymorphisms and human disease. Trends Genet 24: 489-497.
42. Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol 16: 3-9.